ACT-462206

· Idorsia Pharmaceuticals Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ACT-462206, covering 2018-07-10 to 2018-07-10. Get the full timeline:

Most recent: Clinical Trial Update: Single-ascending Dose Study to Investigate the Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics of ACT-462206 [Phase 1]

See pricing